Add like
Add dislike
Add to saved papers

ACTOR: Adaptive Control of Transmission Power in RPL.

Sensors 2024 April 7
RPL- Routing Protocol for Low-Power and Lossy Networks (usually pronounced "ripple")-is the de facto standard for IoT networks. However, it neglects to exploit IoT devices' full capacity to optimize their transmission power, mainly because it is quite challenging to do so in parallel with the routing strategy, given the dynamic nature of wireless links and the typically constrained resources of IoT devices. Adapting the transmission power requires dynamically assessing many parameters, such as the probability of packet collisions, energy consumption, the number of hops, and interference. This paper introduces Adaptive Control of Transmission Power for RPL (ACTOR) for the dynamic optimization of transmission power. ACTOR aims to improve throughput in dense networks by passively exploring different transmission power levels. The classic solutions of bandit theory, including the Upper Confidence Bound (UCB) and Discounted UCB , accelerate the convergence of the exploration and guarantee its optimality. ACTOR is also enhanced via mechanisms to blacklist undesirable transmission power levels and stabilize the topology of parent-child negotiations. The results of the experiments conducted on our 40-node, 12-node testbed demonstrate that ACTOR achieves a higher packet delivery ratio by almost 20%, reduces the transmission power of nodes by up to 10 dBm, and maintains a stable topology with significantly fewer parent switches compared to the standard RPL and the selected benchmarks. These findings are consistent with simulations conducted across 7 different scenarios, where improvements in end-to-end delay, packet delivery, and energy consumption were observed by up to 50%.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app